Consensus statement: the role of prostate-specific antigen in managing the patient with benign prostatic hyperplasia
โ Scribed by G. Bartsch; J.M. Fitzpatrick; J.A. Schalken; J. Isaacs; J. Nordling; C.G. Roehrborn
- Book ID
- 109051121
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 87 KB
- Volume
- 93
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
T1, 2, 3pN0, M0), 44 patients with BPH, and 54 healthy Charite ยด, Humboldt University Berlin, Berlin, Gercontrols. Prostate volume was determined by transrectal ultrasound. many. ## RESULTS. The median values of t-PSA and f-PSA% were 7.8 mg/L and 10.5% in PCa patients, 4.3 mg/L and 20.8% in patie
Two-dimensional electrophoresis of prostatespecific antigen in sera of men with prostate cancer or benign prostate hyperplasia Prostate-specific antigen (PSA), the main marker for prostate cancer (PCa), is released from the prostate into the blood stream at nanogram level and may increase in PCa and